Danaher Corporation [NYSE: DHR] loss -0.26% or -0.53 points to close at $205.54 with a heavy trading volume of 2081412 shares. The company report on July 23, 2020 that Beckman Coulter’s Automated Blood Banking Analyzer Receives 510(k) FDA Clearance.
Beckman Coulter today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System and the system’s reagents have completed FDA approval. Designed for use in blood donor and plasma centers, as well as large reference laboratories, the PK7400 Automated Microplate System offers the industry’s highest throughput for a single analyzer in its class and is now available in countries across Europe, Canada and the United States.
According to the AABB (formerly the American Association of Blood Banks), an estimated 33,000 units of blood are needed each day to meet patient need. However, the organization also stated, more than 4,000 blood donation events have been cancelled due to the COVID-19 pandemic.
The daily chart for DHR points out that the company has recorded 26.18% gains over the past six months.
If we look at the average trading volume of 2.88M shares, DHR reached to a volume of 2081412 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Danaher Corporation [DHR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DHR shares is $219.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DHR stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wolfe Research have made an estimate for Danaher Corporation shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 16, 2020. The new note on the price target was released on April 02, 2020, representing the official price target for Danaher Corporation stock. Previously, the target price had yet another raise from $151 to $157, while RBC Capital Mkts kept a Outperform rating on DHR stock. On February 03, 2020, analysts increased their price target for DHR shares from 167 to 187.
The Average True Range (ATR) for Danaher Corporation is set at 3.99, with the Price to Sales ratio for DHR stock in the period of the last 12 months amounting to 8.26. The Price to Book ratio for the last quarter was 4.39, with the Price to Cash per share for the same quarter was set at 7.87. Price to Free Cash Flow for DHR in the course of the last twelve months was 45.51 with Quick ratio for the last quarter at 1.70.
Trading performance analysis for DHR stock
Danaher Corporation [DHR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.69. With this latest performance, DHR shares gained by 12.91% in over the last four-week period, additionally plugging by 26.18% over the last 6 months – not to mention a rise of 48.69% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DHR stock in for the last two-week period is set at 74.69, with the RSI for the last a single of trading hit 77.47, and the three-weeks RSI is set at 73.43 for Danaher Corporation [DHR]. The present Moving Average for the last 50 days of trading for this stock 181.67, while it was recorded at 204.88 for the last single week of trading, and 158.11 for the last 200 days.
Danaher Corporation [DHR]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Danaher Corporation [DHR] shares currently have an operating margin of +18.77 and a Gross Margin at +55.74. Danaher Corporation’s Net Margin is presently recorded at +13.58.
Return on Total Capital for DHR is now 7.41, given the latest momentum, and Return on Invested Capital for the company is 5.39. Return on Equity for this stock inclined to 8.32, with Return on Assets sitting at 4.43. When it comes to the capital structure of this company, Danaher Corporation [DHR] has a Total Debt to Total Equity ratio set at 74.42. Additionally, DHR Total Debt to Total Capital is recorded at 42.67, with Total Debt to Total Assets ending up at 36.28. Long-Term Debt to Equity for the company is recorded at 77.28, with the Long-Term Debt to Total Capital now at 41.96.
Reflecting on the efficiency of the workforce at the company, Danaher Corporation [DHR] managed to generate an average of $40,538 per employee. Receivables Turnover for the company is 5.30 with a Total Asset Turnover recorded at a value of 0.33.Danaher Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.70 and a Current Ratio set at 2.20.
Danaher Corporation [DHR]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Danaher Corporation posted 1.06/share EPS, while the average EPS was predicted by analysts to be reported at 1.15/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -7.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DHR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Danaher Corporation go to 13.02%.
An analysis of insider ownership at Danaher Corporation [DHR]
There are presently around $114,248 million, or 80.00% of DHR stock, in the hands of institutional investors. The top three institutional holders of DHR stocks are: VANGUARD GROUP INC with ownership of 50,901,306, which is approximately 2.937% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 41,686,536 shares of the stock with an approximate value of $8.57 billion in DHR stocks shares; and PRICE T ROWE ASSOCIATES INC /MD/, currently with $8.15 billion in DHR stock with ownership of nearly -1.584% of the company’s market capitalization.
Positions in Danaher Corporation stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 655 institutional holders increased their position in Danaher Corporation [NYSE:DHR] by around 29,897,295 shares. Additionally, 771 investors decreased positions by around 32,726,501 shares, while 209 investors held positions by with 493,221,763 shares. The mentioned changes placed institutional holdings at 555,845,559 shares, according to the latest SEC report filing. DHR stock had 145 new institutional investments in for a total of 7,448,668 shares, while 98 institutional investors sold positions of 2,170,757 shares during the same period.